\-\ Texto\\:\\ \ \(0\)\
\-\ physical\\ exam\\ is\\ remarkable\\ for\\ fine\\ crackles\\ over\\ the\\ left\\ lower\\ posterior\\ hemithorax\\.\ \(0\)\
\-\ this\\ patient\\‚\\Ä\\ôs\\ radiograph\\ returned\\ to\\ normal\\ and\\ his\\ symptoms\\ resolved\\ after\\ two\\ months\\ of\\ treatment\\ with\\ oral\\ corticosteroids\\.\ \(0\)\
\-\ \\‚\\Ä\\úgarland\\‚\\Ä\\ôs\\ triad\\‚\\Ä\\ù\\ \\(\\‚\\Ä\\ú1\\-2\\-3\\‚\\Ä\\ù\\ sign\\)\\ of\\ thoracic\\ lymphadenopathy\\:\\ there\\ are\\ bilateral\\ hilar\\ and\\ right\\ paratracheal\\ opacities\\,\\ the\\ lobulated\\ contours\\ being\\ typical\\ of\\ lymph\\ node\\ enlargement\\.\ \(0\)\
\-\ note\\ also\\ the\\ lymphadenopathy\\ at\\ the\\ aorticopulmonary\\ window\\ region\\.\ \(0\)\
\-\ also\\ noted\\ is\\ a\\ reticulonodular\\ interstitial\\ pattern\\ at\\ the\\ lung\\ bases\\,\\ left\\ greater\\ than\\ right\\.\ \(0\)\
\-\ incidental\\ findings\\ include\\ degenerative\\ changes\\ of\\ the\\ right\\ shoulder\\ joint\\,\\ with\\ calcification\\ of\\ the\\ coracoclavicular\\ ligament\\.\ \(0\)\
\-\ stage\\ ii\\ sarcoidosis\\ manifiesting\\ with\\ garland\\‚\\Ä\\ôs\\ triad\\,\\ aorticopulmonary\\ window\\ lymphadenopathy\\ and\\ parenchymal\\ disease\\ at\\ the\\ lung\\ bases\\.\ \(0\)\
\-\ differential\\ diagnostic\\ considerations\\ for\\ bilateral\\ hilar\\ opacities\\ include\\ two\\ major\\ categories\\ of\\ pathology\\:\\ \\(bilaterally\\)\\ enlarged\\ pulmonary\\ arteries\\ \\(pulmonary\\ arterial\\ hypertension\\ \\[pah\\]\\)\\ and\\ bilateral\\ hilar\\ lymphadenopathy\\.\\ \ \(0\)\
\-\ pulmonary\\ arterial\\ hypertension\\ may\\ be\\ divided\\ into\\ \\(1\\)\\ cardiac\\ causes\\ including\\ left\\-sided\\ heart\\ failure\\,\\ mitral\\ stenosis\\,\\ left\\ atrial\\ myxoma\\,\\ and\\ cardiac\\ shunts\\ \\(vsd\\,\\ asd\\,\\ pda\\,\\ truncus\\ arteriosis\\,\\ and\\ transposition\\ of\\ the\\ great\\ vessels\\)\\ and\\ \\(2\\)\\ pulmonary\\ causes\\ including\\ emphysema\\;\\ chronic\\ interstitial\\ lung\\ disease\\,\\ acute\\ and\\ chronic\\ pulmonary\\ emboli\\;\\ portal\\ hypertension\\;\\ metastatic\\ tumor\\ emboli\\;\\ and\\ idiopathic\\ \\(primary\\)\\ pulmonary\\ hypertension\\ \\(plexogenic\\ pulmonary\\ arteriopathy\\)\\.\\ \ \(0\)\
\-\ the\\ three\\ major\\ etiologies\\ of\\ bilateral\\ hilar\\ adenopathy\\ are\\:\\ \ \(0\)\
\-\ \\(1\\)\\ neoplasms\\ including\\ lymphoma\\,\\ leukemia\\ \\(cll\\)\\,\\ metastases\\ \\(e\\.g\\.\\,\\ renal\\ cell\\ carcinoma\\)\\ and\\,\\ rarely\\,\\ primary\\ bronchogenic\\ carcinoma\\ \\(usually\\ unilateral\\ or\\ asymmetric\\)\\;\\ \ \(0\)\
\-\ \\(2\\)\\ inflammation\\ including\\ sarcoidosis\\ or\\ occupation\\ lung\\ diseases\\ like\\ silicosis\\,\\ and\\ \ \(1\)\
\-\ \\(3\\)\\ collagen\\-vascular\\ diseases\\ including\\ lupus\\ \\(rarely\\)\\,\\ polyarteritis\\ nodosa\\,\\ and\\ mixed\\ connective\\ tissues\\ diseases\\.\\ neoplastic\\ and\\ inflammatory\\ diseases\\ that\\ more\\ commonly\\ present\\ as\\ unilateral\\ hilar\\ adenopathy\\ include\\,\\ in\\ the\\ neoplastic\\ category\\,\\ bronchogenic\\ carcinoma\\,\\ metastases\\,\\ and\\ lymphoma\\ and\\,\\ in\\ the\\ inflammatory\\ category\\,\\ tuberculosis\\,\\ fungal\\ infections\\ \\(including\\ histoplasmosis\\,\\ coccidioidomycosis\\,\\ and\\ blastomycosis\\)\\,\\ viral\\ infections\\ \\(including\\ atypical\\ measles\\)\\,\\ infectious\\ mononucleosis\\,\\ aids\\,\\ drug\\ reactions\\ \\(e\\.g\\.\\,\\ phenytoin\\/dilantin\\)\\,\\ and\\ bilateral\\ lung\\ abscesses\\.\ \(0\)\
\-\ a\\ 41\\ year\\-old\\ black\\ male\\ nonsmoker\\ with\\ a\\ 1\\-year\\ history\\ of\\ progressive\\ dyspnea\\ on\\ exertion\\,\\ cough\\,\\ chest\\ discomfort\\,\\ weight\\ loss\\,\\ and\\ anorexia\\.\ \(0\)\
\-\ the\\ radiographic\\ manifestations\\ of\\ sarcoidosis\\ are\\ classified\\ into\\ three\\ major\\ stages\\ as\\ follows\\:\\ \ \(0\)\
\-\ stage\\ i\\:\\ hilar\\ or\\ mediastinal\\ adenopathy\\ \\(or\\ both\\)\\ without\\ associated\\ parenchymal\\ disease\\ \ \(0\)\
\-\ stage\\ ii\\:\\ concomitant\\ lymphadenopathy\\ and\\ parenchymal\\ disease\\ \ \(0\)\
\-\ stage\\ iii\\:\\ diffuse\\ parenchymal\\ disease\\ without\\ associated\\ lymphadenopathy\\ \ \(0\)\
\-\ other\\ stages\\ sometimes\\ mentioned\\ include\\ stage\\ 0\\ \\(normal\\ chest\\ radiograph\\)\\ and\\ stage\\ iv\\ \\(pulmonary\\ fibrosis\\)\\.\\ \ \(0\)\
\-\ the\\ staging\\ system\\ is\\ important\\ for\\ two\\ main\\ reasons\\:\\ it\\ is\\ a\\ means\\ of\\ describing\\ the\\ radiographic\\ findings\\ \\(although\\ patients\\ do\\ not\\ necessarily\\ progress\\ sequentially\\ from\\ one\\ stage\\ to\\ the\\ next\\)\\ and\\ it\\ has\\ been\\ shown\\ to\\ correlate\\ with\\ clinical\\ outcome\\.\\ in\\ a\\ survey\\ of\\ 3\\,676\\ patients\\ with\\ sarcoidosis\\ from\\ nine\\ countries\\,\\ 8\\%\\ had\\ stage\\ 0\\ disease\\,\\ 51\\%\\ had\\ stage\\ i\\ disease\\,\\ 29\\%\\ had\\ stage\\ ii\\ disease\\,\\ and\\ 12\\%\\ had\\ stage\\ iii\\ disease\\ and\\,\\ on\\ follow\\-up\\,\\ 65\\%\\ of\\ patients\\ with\\ stage\\ i\\ disease\\ showed\\ resolution\\ of\\ radiographic\\ findings\\ versus\\ 49\\%\\ of\\ those\\ with\\ stage\\ ii\\ disease\\ and\\ 20\\%\\ of\\ those\\ with\\ stage\\ iii\\ disease\\.\\ sites\\ of\\ lymph\\ node\\ enlargement\\ in\\ decreasing\\ order\\ of\\ frequency\\ include\\ the\\ hilar\\,\\ the\\ right\\ paratracheal\\ region\\,\\ the\\ aortopulmonary\\ window\\,\\ the\\ subcarinal\\ space\\,\\ the\\ anterior\\ mediastinum\\,\\ and\\ the\\ posterior\\ mediastinum\\.\\ the\\ \\‚\\Ä\\ú1\\-2\\-3\\‚\\Ä\\ù\\ sign\\ is\\ a\\ common\\ radiographic\\ finding\\ in\\ sarcoidosis\\ and\\ denotes\\ the\\ combination\\ of\\ bilateral\\ hilar\\ and\\ right\\ paratracheal\\ lymph\\ enlargement\\.\\ the\\ parenchymal\\ abnormalities\\ in\\ sarcoidosis\\ are\\ usually\\ bilateral\\ and\\ symmetrical\\ and\\ may\\ have\\ an\\ upper\\ lung\\ zone\\ predominance\\;\\ the\\ most\\ frequent\\ patterns\\ are\\ the\\ nodular\\ pattern\\ and\\ the\\ reticulonodular\\ pattern\\;\\,\\ less\\ frequently\\,\\ a\\ reticular\\ pattern\\,\\ air\\-space\\ consolidation\\,\\ or\\ ground\\-glass\\ opacities\\ are\\ the\\ dominant\\ roentgenographic\\ finding\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ stage\\:\\ 0\\.3736476929843827\ \(0\)\
\-\ hilar\\:\\ 0\\.24585162716368125\ \(0\)\
\-\ and\\:\\ 0\\.20775978873339518\ \(0\)\
\-\ the\\:\\ 0\\.19393238196473428\ \(0\)\
\-\ sarcoidosis\\:\\ 0\\.1703361899921792\ \(0\)\
\-\ disease\\:\\ 0\\.16881750912132587\ \(0\)\
\-\ including\\:\\ 0\\.16789161890941476\ \(0\)\
\-\ pulmonary\\:\\ 0\\.16342824084544835\ \(0\)\
\-\ lymphadenopathy\\:\\ 0\\.1625668109219983\ \(0\)\
\-\ parenchymal\\:\\ 0\\.15053223130068688\ \(0\)\
\-\ bilateral\\:\\ 0\\.1260828692384389\ \(0\)\
\-\ of\\:\\ 0\\.12461352034781087\ \(0\)\
\-\ diseases\\:\\ 0\\.12316684992212498\ \(0\)\
\-\ lung\\:\\ 0\\.12232293132824007\ \(0\)\
\-\ paratracheal\\:\\ 0\\.11137914964031895\ \(0\)\
\-\ ii\\:\\ 0\\.10569611570760465\ \(0\)\
\-\ window\\:\\ 0\\.1033641393551882\ \(0\)\
\-\ hypertension\\:\\ 0\\.10257242062982459\ \(0\)\
\-\ garland\\:\\ 0\\.10242903959603653\ \(0\)\
\-\ aorticopulmonary\\:\\ 0\\.10242903959603653\ \(0\)\
\-\ pattern\\:\\ 0\\.10008627627560639\ \(0\)\
\-\ include\\:\\ 0\\.09970361057371821\ \(0\)\
\-\ radiographic\\:\\ 0\\.09945955014352419\ \(0\)\
\-\ opacities\\:\\ 0\\.09599302891689963\ \(0\)\
\-\ major\\:\\ 0\\.0879052295877587\ \(0\)\
\-\ iii\\:\\ 0\\.08681181687253484\ \(0\)\
\-\ adenopathy\\:\\ 0\\.08457458343737602\ \(0\)\
\-\ reticulonodular\\:\\ 0\\.08204675112391051\ \(0\)\
\-\ triad\\:\\ 0\\.07901715116720409\ \(0\)\
\-\ lymph\\:\\ 0\\.0781832220277992\ \(0\)\
\-\ enlargement\\:\\ 0\\.0770812614812382\ \(0\)\
\-\ category\\:\\ 0\\.07705419574671993\ \(0\)\
\-\ are\\:\\ 0\\.07630298750115297\ \(0\)\
\-\ stages\\:\\ 0\\.0717021676312232\ \(0\)\
\-\ bases\\:\\ 0\\.06890942623679214\ \(0\)\
\-\ had\\:\\ 0\\.06679228874645139\ \(0\)\
\-\ emboli\\:\\ 0\\.06575721210405491\ \(0\)\
\-\ bronchogenic\\:\\ 0\\.06445026433455481\ \(0\)\
\-\ neoplastic\\:\\ 0\\.06195257841703243\ \(0\)\
\-\ unilateral\\:\\ 0\\.061343612176626705\ \(0\)\
\-\ interstitial\\:\\ 0\\.06076465672686434\ \(0\)\
\-\ carcinoma\\:\\ 0\\.060140274907592634\ \(0\)\
\-\ mediastinum\\:\\ 0\\.05999924266027111\ \(0\)\
\-\ rarely\\:\\ 0\\.059789408180958896\ \(0\)\
\-\ two\\:\\ 0\\.05970789931275927\ \(0\)\
\-\ infections\\:\\ 0\\.05918149235119\ \(0\)\
\-\ with\\:\\ 0\\.05906272589835391\ \(0\)\
\-\ or\\:\\ 0\\.05829519580868678\ \(0\)\
\-\ node\\:\\ 0\\.057612442594127115\ \(0\)\
\-\ those\\:\\ 0\\.057356059654198\ \(0\)\
\-\ patients\\:\\ 0\\.05656093310877717\ \(0\)\
\-\ right\\:\\ 0\\.05555693788758708\ \(0\)\
\-\ arterial\\:\\ 0\\.05519962425462346\ \(0\)\
\-\ metastases\\:\\ 0\\.05418893697399943\ \(0\)\
\-\ manifiesting\\:\\ 0\\.053596712168180655\ \(0\)\
\-\ plexogenic\\:\\ 0\\.053596712168180655\ \(0\)\
\-\ sequentially\\:\\ 0\\.053596712168180655\ \(0\)\
\-\ roentgenographic\\:\\ 0\\.05121451979801826\ \(0\)\
\-\ causes\\:\\ 0\\.05064824387104281\ \(0\)\
\-\ in\\:\\ 0\\.05002366800337493\ \(0\)\
\-\ cardiac\\:\\ 0\\.04977403282118767\ \(0\)\
\-\ findings\\:\\ 0\\.0496220005949417\ \(0\)\
\-\ arteriosis\\:\\ 0\\.04952432741321675\ \(0\)\
\-\ aortopulmonary\\:\\ 0\\.04952432741321675\ \(0\)\
\-\ denotes\\:\\ 0\\.04952432741321675\ \(0\)\
\-\ cll\\:\\ 0\\.04821331234740289\ \(0\)\
\-\ reactions\\:\\ 0\\.04821331234740289\ \(0\)\
\-\ countries\\:\\ 0\\.04821331234740289\ \(0\)\
\-\ coracoclavicular\\:\\ 0\\.04714213504305436\ \(0\)\
\-\ pah\\:\\ 0\\.04714213504305436\ \(0\)\
\-\ arteriopathy\\:\\ 0\\.04714213504305436\ \(0\)\
\-\ nonsmoker\\:\\ 0\\.04714213504305436\ \(0\)\
\-\ sign\\:\\ 0\\.04640473858433924\ \(0\)\
\-\ truncus\\:\\ 0\\.04623646753678431\ \(0\)\
\-\ describing\\:\\ 0\\.04623646753678431\ \(0\)\
\-\ is\\:\\ 0\\.04589063689665238\ \(0\)\
\-\ left\\:\\ 0\\.04572987769662569\ \(0\)\
\-\ blastomycosis\\:\\ 0\\.04545194265825286\ \(0\)\
\-\ measles\\:\\ 0\\.04545194265825286\ \(0\)\
\-\ inflammatory\\:\\ 0\\.04532420961889045\ \(0\)\
\-\ three\\:\\ 0\\.04499487696819347\ \(0\)\
\-\ occupation\\:\\ 0\\.04475994267289197\ \(0\)\
\-\ polyarteritis\\:\\ 0\\.04475994267289197\ \(0\)\
\-\ space\\:\\ 0\\.04461720430625034\ \(0\)\
\-\ finding\\:\\ 0\\.04405888462903047\ \(0\)\
\-\ radiograph\\:\\ 0\\.043656892681491616\ \(0\)\
\-\ coccidioidomycosis\\:\\ 0\\.04358096033856594\ \(0\)\
\-\ mononucleosis\\:\\ 0\\.04358096033856594\ \(0\)\
\-\ nodosa\\:\\ 0\\.043069750288090465\ \(0\)\
\-\ usually\\:\\ 0\\.04219702681943782\ \(0\)\
\-\ transposition\\:\\ 0\\.042164082781820406\ \(0\)\
\-\ subcarinal\\:\\ 0\\.042164082781820406\ \(0\)\
\-\ shunts\\:\\ 0\\.0417587352222766\ \(0\)\
\-\ necessarily\\:\\ 0\\.04137955790328896\ \(0\)\
\-\ primary\\:\\ 0\\.04121539670741138\ \(0\)\
\-\ myxoma\\:\\ 0\\.041023375561955254\ \(0\)\
\-\ contours\\:\\ 0\\.040369901677205194\ \(0\)\
\-\ region\\:\\ 0\\.04009351660506175\ \(0\)\
\-\ anorexia\\:\\ 0\\.040068542837475095\ \(0\)\
\-\ lymphoma\\:\\ 0\\.03991971924242113\ \(0\)\
\-\ chronic\\:\\ 0\\.03978629861991438\ \(0\)\
\-\ categories\\:\\ 0\\.039781890411658014\ \(0\)\
\-\ pda\\:\\ 0\\.039781890411658014\ \(0\)\
\-\ silicosis\\:\\ 0\\.039781890411658014\ \(0\)\
\-\ vsd\\:\\ 0\\.0392474121751633\ \(0\)\
\-\ nine\\:\\ 0\\.0392474121751633\ \(0\)\
\-\ classified\\:\\ 0\\.038527097873359964\ \(0\)\
\-\ reticular\\:\\ 0\\.038305365547765674\ \(0\)\
\-\ concomitant\\:\\ 0\\.03809169802685651\ \(0\)\
\-\ at\\:\\ 0\\.03797636186954602\ \(0\)\
\-\ symmetrical\\:\\ 0\\.03788552917868268\ \(0\)\
\-\ decreasing\\:\\ 0\\.0376863504673127\ \(0\)\
\-\ patterns\\:\\ 0\\.0376863504673127\ \(0\)\
\-\ means\\:\\ 0\\.03749370339562665\ \(0\)\
\-\ divided\\:\\ 0\\.03730717314832506\ \(0\)\
\-\ histoplasmosis\\:\\ 0\\.03730717314832506\ \(0\)\
\-\ asd\\:\\ 0\\.03712638321343965\ \(0\)\
\-\ predominance\\:\\ 0\\.03712638321343965\ \(0\)\
\-\ correlate\\:\\ 0\\.03695099080699135\ \(0\)\
\-\ survey\\:\\ 0\\.03661517316296417\ \(0\)\
\-\ mitral\\:\\ 0\\.03645419845526185\ \(0\)\
\-\ aids\\:\\ 0\\.03645419845526185\ \(0\)\
\-\ corticosteroids\\:\\ 0\\.0362975169222413\ \(0\)\
\-\ outcome\\:\\ 0\\.03570950565669411\ \(0\)\
\-\ into\\:\\ 0\\.03563128336708544\ \(0\)\
\-\ reasons\\:\\ 0\\.03557125905969781\ \(0\)\
\-\ mentioned\\:\\ 0\\.035436190828638144\ \(0\)\
\-\ chest\\:\\ 0\\.035381124952138174\ \(0\)\
\-\ without\\:\\ 0\\.0353550996511755\ \(0\)\
\-\ associated\\:\\ 0\\.03532913186473696\ \(0\)\
\-\ exertion\\:\\ 0\\.03517502742019941\ \(0\)\
\-\ lupus\\:\\ 0\\.03492498077816267\ \(0\)\
\-\ connective\\:\\ 0\\.03480383815042405\ \(0\)\
\-\ considerations\\:\\ 0\\.03468514301669733\ \(0\)\
\-\ posterior\\:\\ 0\\.03466109978378242\ \(0\)\
\-\ crackles\\:\\ 0\\.03456879843682896\ \(0\)\
\-\ black\\:\\ 0\\.0343428009863355\ \(0\)\
\-\ manifestations\\:\\ 0\\.0343428009863355\ \(0\)\
\-\ it\\:\\ 0\\.034311035744913426\ \(0\)\
\-\ staging\\:\\ 0\\.03423298079280178\ \(0\)\
\-\ fine\\:\\ 0\\.034125175762824284\ \(0\)\
\-\ hemithorax\\:\\ 0\\.034125175762824284\ \(0\)\
\-\ progress\\:\\ 0\\.034125175762824284\ \(0\)\
\-\ abscesses\\:\\ 0\\.03401931327189261\ \(0\)\
\-\ may\\:\\ 0\\.0337309367800046\ \(0\)\
\-\ etiologies\\:\\ 0\\.0336139657123488\ \(0\)\
\-\ great\\:\\ 0\\.0331436980525822\ \(0\)\
\-\ remarkable\\:\\ 0\\.03305399845847575\ \(0\)\
\-\ emphysema\\:\\ 0\\.032878606052027456\ \(0\)\
\-\ follows\\:\\ 0\\.03279283505003701\ \(0\)\
\-\ sites\\:\\ 0\\.03270829820607874\ \(0\)\
\-\ zone\\:\\ 0\\.03238181370029795\ \(0\)\
\-\ portal\\:\\ 0\\.03207252074823368\ \(0\)\
\-\ 51\\:\\ 0\\.03199767630563321\ \(0\)\
\-\ frequency\\:\\ 0\\.03185078842263938\ \(0\)\
\-\ 49\\:\\ 0\\.031637120901730216\ \(0\)\
\-\ also\\:\\ 0\\.03152836208520994\ \(0\)\
\-\ returned\\:\\ 0\\.031498874304733915\ \(0\)\
\-\ atrial\\:\\ 0\\.031498874304733915\ \(0\)\
\-\ sometimes\\:\\ 0\\.03136380607367425\ \(0\)\
\-\ dominant\\:\\ 0\\.03136380607367425\ \(0\)\
\-\ next\\:\\ 0\\.031297418821666936\ \(0\)\
\-\ neoplasms\\:\\ 0\\.03123177334218641\ \(0\)\
\-\ combination\\:\\ 0\\.03110264266523551\ \(0\)\
\-\ discomfort\\:\\ 0\\.030976289208516215\ \(0\)\
\-\ order\\:\\ 0\\.030976289208516215\ \(0\)\
\-\ consolidation\\:\\ 0\\.030976289208516215\ \(0\)\
\-\ lobulated\\:\\ 0\\.03091411710146353\ \(0\)\
\-\ viral\\:\\ 0\\.03091411710146353\ \(0\)\
\-\ 41\\:\\ 0\\.030731453395460157\ \(0\)\
\-\ frequent\\:\\ 0\\.030731453395460157\ \(0\)\
\-\ leukemia\\:\\ 0\\.030612758261733434\ \(0\)\
\-\ drug\\:\\ 0\\.03049641368186506\ \(0\)\
\-\ for\\:\\ 0\\.0304738100024687\ \(0\)\
\-\ asymmetric\\:\\ 0\\.03016059603783788\ \(0\)\
\-\ resolved\\:\\ 0\\.030106446260137372\ \(0\)\
\-\ fungal\\:\\ 0\\.029999621330135555\ \(0\)\
\-\ versus\\:\\ 0\\.029640326295065154\ \(0\)\
\-\ tuberculosis\\:\\ 0\\.029492823753987332\ \(0\)\
\-\ dyspnea\\:\\ 0\\.029492823753987332\ \(0\)\
\-\ main\\:\\ 0\\.029208483947483935\ \(0\)\
\-\ 29\\:\\ 0\\.029208483947483935\ \(0\)\
\-\ ligament\\:\\ 0\\.028806221297063558\ \(0\)\
\-\ 65\\:\\ 0\\.028678029827099\ \(0\)\
\-\ degenerative\\:\\ 0\\.028470403653036377\ \(0\)\
\-\ important\\:\\ 0\\.028389364998696535\ \(0\)\
\-\ idiopathic\\:\\ 0\\.02834926102529776\ \(0\)\
\-\ fibrosis\\:\\ 0\\.028075946197241793\ \(0\)\
\-\ do\\:\\ 0\\.027778403667675484\ \(0\)\
\-\ mixed\\:\\ 0\\.02774224841947993\ \(0\)\
\-\ frequently\\:\\ 0\\.02759981212731173\ \(0\)\
\-\ atypical\\:\\ 0\\.02749520623124969\ \(0\)\
\-\ normal\\:\\ 0\\.02736735366163602\ \(0\)\
\-\ resolution\\:\\ 0\\.027192119642855297\ \(0\)\
\-\ mediastinal\\:\\ 0\\.027062275478831985\ \(0\)\
\-\ infectious\\:\\ 0\\.02696674151553646\ \(0\)\
\-\ inflammation\\:\\ 0\\.02693523897737664\ \(0\)\
\-\ as\\:\\ 0\\.026927792804031903\ \(0\)\
\-\ oral\\:\\ 0\\.026841732346499638\ \(0\)\
\-\ nodular\\:\\ 0\\.026689120927455907\ \(0\)\
\-\ from\\:\\ 0\\.02662094322766694\ \(0\)\
\-\ arteries\\:\\ 0\\.02659942133334946\ \(0\)\
\-\ tissues\\:\\ 0\\.026424028926901162\ \(0\)\
\-\ pathology\\:\\ 0\\.02630994360846827\ \(0\)\
\-\ shoulder\\:\\ 0\\.026034061505173473\ \(0\)\
\-\ vessels\\:\\ 0\\.026007172628534143\ \(0\)\
\-\ shown\\:\\ 0\\.025980406252896483\ \(0\)\
\-\ typical\\:\\ 0\\.025900831095709703\ \(0\)\
\-\ progressive\\:\\ 0\\.025668374913790988\ \(0\)\
\-\ system\\:\\ 0\\.025567941540101256\ \(0\)\
\-\ diagnostic\\:\\ 0\\.02554309918050691\ \(0\)\
\-\ stenosis\\:\\ 0\\.025493727383323478\ \(0\)\
\-\ failure\\:\\ 0\\.025444767022565255\ \(0\)\
\-\ note\\:\\ 0\\.025229358440955668\ \(0\)\
\-\ to\\:\\ 0\\.025135551132303147\ \(0\)\
\-\ thoracic\\:\\ 0\\.025044297179607624\ \(0\)\
\-\ cough\\:\\ 0\\.025021569068901597\ \(0\)\
\-\ like\\:\\ 0\\.024909228948547954\ \(0\)\
\-\ incidental\\:\\ 0\\.024842841696540646\ \(0\)\
\-\ commonly\\:\\ 0\\.02479899664760407\ \(0\)\
\-\ greater\\:\\ 0\\.024690794523287565\ \(0\)\
\-\ abnormalities\\:\\ 0\\.024276876270333862\ \(0\)\
\-\ iv\\:\\ 0\\.023946612279514033\ \(0\)\
\-\ calcification\\:\\ 0\\.02392775123830588\ \(0\)\
\-\ weight\\:\\ 0\\.023371208764063803\ \(0\)\
\-\ being\\:\\ 0\\.02335410479480612\ \(0\)\
\-\ heart\\:\\ 0\\.023303089632391295\ \(0\)\
\-\ 12\\:\\ 0\\.02291017159997525\ \(0\)\
\-\ enlarged\\:\\ 0\\.022847166070793276\ \(0\)\
\-\ although\\:\\ 0\\.022815914883861994\ \(0\)\
\-\ less\\:\\ 0\\.022800351406441526\ \(0\)\
\-\ bilaterally\\:\\ 0\\.022351644171937263\ \(0\)\
\-\ showed\\:\\ 0\\.022322914484906038\ \(0\)\
\-\ joint\\:\\ 0\\.022084223217598026\ \(0\)\
\-\ differential\\:\\ 0\\.021775988766444744\ \(0\)\
\-\ 20\\:\\ 0\\.021621369072115502\ \(0\)\
\-\ clinical\\:\\ 0\\.02123980781749338\ \(0\)\
\-\ diffuse\\:\\ 0\\.02101763412846947\ \(0\)\
\-\ renal\\:\\ 0\\.020870321260174688\ \(0\)\
\-\ loss\\:\\ 0\\.02041815903627913\ \(0\)\
\-\ his\\:\\ 0\\.02032563414310858\ \(0\)\
\-\ changes\\:\\ 0\\.020254664401756887\ \(0\)\
\-\ on\\:\\ 0\\.020243806757770894\ \(0\)\
\-\ been\\:\\ 0\\.019525829127770192\ \(0\)\
\-\ months\\:\\ 0\\.019508052384130656\ \(0\)\
\-\ one\\:\\ 0\\.019188528032329857\ \(0\)\
\-\ cell\\:\\ 0\\.019171741708651786\ \(0\)\
\-\ common\\:\\ 0\\.019006464725825296\ \(0\)\
\-\ than\\:\\ 0\\.018998321676301944\ \(0\)\
\-\ anterior\\:\\ 0\\.018712444292935764\ \(0\)\
\-\ both\\:\\ 0\\.018689237379455322\ \(0\)\
\-\ over\\:\\ 0\\.018635441758307076\ \(0\)\
\-\ more\\:\\ 0\\.018402952602290815\ \(0\)\
\-\ metastatic\\:\\ 0\\.01838093430310154\ \(0\)\
\-\ symptoms\\:\\ 0\\.01833714372056888\ \(0\)\
\-\ physical\\:\\ 0\\.01817223989529179\ \(0\)\
\-\ acute\\:\\ 0\\.01812997202024777\ \(0\)\
\-\ upper\\:\\ 0\\.01790953972105459\ \(0\)\
\-\ noted\\:\\ 0\\.017769249490961377\ \(0\)\
\-\ tumor\\:\\ 0\\.01752993986193296\ \(0\)\
\-\ most\\:\\ 0\\.01744187297739164\ \(0\)\
\-\ other\\:\\ 0\\.017404530419746333\ \(0\)\
\-\ present\\:\\ 0\\.017197292009884787\ \(0\)\
\-\ lower\\:\\ 0\\.01712586001396826\ \(0\)\
\-\ exam\\:\\ 0\\.016871131242768976\ \(0\)\
\-\ have\\:\\ 0\\.01674224690066604\ \(0\)\
\-\ after\\:\\ 0\\.016258351611036406\ \(0\)\
\-\ treatment\\:\\ 0\\.01596465442328177\ \(0\)\
\-\ has\\:\\ 0\\.015308370105906691\ \(0\)\
\-\ male\\:\\ 0\\.014921869625024287\ \(0\)\
\-\ that\\:\\ 0\\.014543963033691775\ \(0\)\
\-\ be\\:\\ 0\\.01359542446166612\ \(0\)\
\-\ there\\:\\ 0\\.013335248495216622\ \(0\)\
\-\ not\\:\\ 0\\.013230660855947164\ \(0\)\
\-\ an\\:\\ 0\\.012815767868973711\ \(0\)\
\-\ history\\:\\ 0\\.012804414804009904\ \(0\)\
\-\ this\\:\\ 0\\.011516127848902062\ \(0\)\
\-\ patient\\:\\ 0\\.010900529581159857\ \(0\)\
